Takeda Pharmaceutical (NYSE: TAK)
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-07-29 | ||||||
REV |
Q4 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.400 | ||||||
REV | 7.517B |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Takeda Pharmaceutical (NYSE: TAK) through any online brokerage.
Other companies in Takeda Pharmaceutical’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Roivant Sciences (NASDAQ:ROIV).
The latest price target for Takeda Pharmaceutical (NYSE: TAK) was reported by Morgan Stanley on Thursday, October 7, 2021. The analyst firm set a price target for 0.00 expecting TAK to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Takeda Pharmaceutical (NYSE: TAK) is $13.84 last updated June 24, 2022, 7:59 PM UTC.
There are no upcoming dividends for Takeda Pharmaceutical.
Takeda Pharmaceutical’s Q1 earnings are confirmed for Friday, July 29, 2022.
There is no upcoming split for Takeda Pharmaceutical.
Takeda Pharmaceutical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.